Platelet-rich and platelet-poor plasma: development of an animal model to evaluate hemostatic efficacy.
Hemostasis is important for any surgical procedure. One method uses autologous platelet-rich and/or platelet-poor plasma sprayed on the wound site. Although effective, there are little quantitative data available to fully document the extent to which these autologous products function as hemostats. Also, limitations in current animal models make quantitative study of topical hemostats difficult. A porcine partial-thickness skin wound model was developed to compare the hemostatic ability of these treatments with untreated control wounds. Rectangular partial-thickness dermal wounds were created in the back of a pig, which was then sprayed with activated platelet-rich plasma, activated platelet-poor plasma, or left untreated. Bleeding was quantified by two methods: 1) gravimetric measurement of exudate transfer to a sponge over a 15-minute interval, and 2) iron assay of the exudate over this same interval. Values for treated wounds were normalized to those of control wounds to minimize interanimal variability. Both gravimetric and iron assay measurements demonstrated that platelet-rich plasma was effective within 5 minutes after application with normalized bleeding values of approximately 35% and 20%, respectively, of the untreated controls. Corresponding values for platelet-poor plasma were approximately 90% and 65%, respectively, with differences only significant for the iron assay method measured on 10- and 15-minute wound exudate. Although both platelet-rich and platelet-poor plasma demonstrated hemostatic potential, the effect was more robust with the former. Iron assay was a more accurate method of measuring bleeding than gravimetric analysis.
Pietrzak
William S
WS
Biomet, Inc., Warsaw, Indiana 46581, USA. bill.pietrzak@biometmail.com
An
Yuehuei H
YH
Kang
Qian K
QK
Demos
Harry A
HA
Ehrens
Karl H
KH
D000818:Animals; D001792:Blood Platelets / Q000502:physiology*; D004195:Disease Models, Animal; D005122:Exudates and Transudates / Q000737:chemistry; D006470:Hemorrhage / Q000517:prevention & control; D006488:Hemostasis, Surgical / Q000379:methods; D006490:Hemostatics / Q000627:therapeutic use*; D019934:International Normalized Ratio; D007501:Iron / Q000032:analysis; D010949:Plasma; D015539:Platelet Activation / Q000502:physiology; D053657:Platelet-Rich Plasma; D012867:Skin / Q000293:injuries; D013552:Swine; D013997:Time Factors
D006490:Hemostatics; D007501:Iron